Predatory publishing
Predatory publishing is an exploitative academic publishing business model that involves charging publication fees to authors without providing the editorial and publishing services associated with legitimate journals. The term was coined by Jeffrey Beall, a librarian at the University of Colorado, who created a list of potential, possible, or probable predatory scholarly open-access publishers.
Characteristics[edit | edit source]
Predatory publishers typically exhibit several common characteristics:
- Lack of peer review or inadequate peer review processes.
- Aggressive solicitation of manuscripts from researchers.
- Misleading information about the journal's impact factor and indexing.
- False claims about the editorial board members.
- High publication fees that are often not disclosed until after the paper is accepted.
Impact on Academia[edit | edit source]
Predatory publishing undermines the integrity of academic research by allowing substandard or fraudulent research to be published. This can lead to the dissemination of incorrect or misleading information, which can have serious consequences, especially in fields like medicine and public health.
Identifying Predatory Journals[edit | edit source]
Researchers can identify predatory journals by:
- Checking if the journal is listed in reputable databases like PubMed or Web of Science.
- Reviewing the journal's editorial board and verifying the credentials of its members.
- Looking for transparency in the journal's peer review process and publication fees.
Controversies[edit | edit source]
The concept of predatory publishing has been controversial. Some argue that the term is too broadly applied and that it unfairly targets new or less established journals. Others believe that the focus should be on improving the quality and transparency of all academic publishing.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD